Search by Drug Name or NDC

    NDC 00485-0204-16 Rynex 1; 5; 2.5 mg/5mL; mg/5mL; mg/5mL Details

    Rynex 1; 5; 2.5 mg/5mL; mg/5mL; mg/5mL

    Rynex is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Edwards Pharmaceuticals, Inc. The primary component is BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00485-0204
    Product ID 0485-0204_02940f28-7dcf-f7cd-e063-6294a90af857
    Associated GPIs 43995803080910
    GCN Sequence Number 060622
    GCN Sequence Number Description brompheniram/phenylephrine/DM SOLUTION 1-2.5-5/5 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 26808
    HICL Sequence Number 035368
    HICL Sequence Number Description BROMPHENIRAMINE MALEATE/PHENYLEPHRINE HCL/DEXTROMETHORPHAN
    Brand/Generic Generic
    Proprietary Name Rynex
    Proprietary Name Suffix DM
    Non-Proprietary Name Brompheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 1; 5; 2.5
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Edwards Pharmaceuticals, Inc
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00485-0204-16 (00485020416)

    NDC Package Code 0485-0204-16
    Billing NDC 00485020416
    Package 473 mL in 1 BOTTLE (0485-0204-16)
    Marketing Start Date 2011-03-14
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.04492
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description RYNEX DM LIQUID
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis